Case and Research Letters
Risk of Hepatitis B Virus Reactivation in Patients on Secukinumab for Psoriasis: A Series of 4 Cases
Riesgo de reactivación de infección por virus hepatitis B en pacientes con psoriasis en tratamiento con secukinumab: una serie de 4 casos
Leído
7689
Vecesse ha leído el artículo
1963
Total PDF
5726
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 385 | 43 | 428 |
| 2025 5 | 264 | 35 | 299 |
| 2025 4 | 204 | 18 | 222 |
| 2025 3 | 212 | 23 | 235 |
| 2025 2 | 217 | 31 | 248 |
| 2025 1 | 151 | 18 | 169 |
| 2024 12 | 129 | 39 | 168 |
| 2024 11 | 131 | 62 | 193 |
| 2024 10 | 111 | 42 | 153 |
| 2024 9 | 137 | 15 | 152 |
| 2024 8 | 156 | 47 | 203 |
| 2024 7 | 137 | 37 | 174 |
| 2024 6 | 157 | 43 | 200 |
| 2024 5 | 95 | 29 | 124 |
| 2024 4 | 103 | 21 | 124 |
| 2024 3 | 86 | 25 | 111 |
| 2024 2 | 78 | 28 | 106 |
| 2024 1 | 82 | 36 | 118 |
| 2023 12 | 61 | 14 | 75 |
| 2023 11 | 87 | 20 | 107 |
| 2023 10 | 85 | 19 | 104 |
| 2023 9 | 92 | 33 | 125 |
| 2023 8 | 60 | 16 | 76 |
| 2023 7 | 76 | 25 | 101 |
| 2023 6 | 91 | 21 | 112 |
| 2023 5 | 76 | 19 | 95 |
| 2023 4 | 57 | 13 | 70 |
| 2023 3 | 81 | 26 | 107 |
| 2023 2 | 117 | 20 | 137 |
| 2022 1 | 73 | 21 | 94 |
| 2022 12 | 77 | 38 | 115 |
| 2022 11 | 39 | 24 | 63 |
| 2022 10 | 39 | 23 | 62 |
| 2022 9 | 40 | 39 | 79 |
| 2022 8 | 27 | 34 | 61 |
| 2022 7 | 30 | 40 | 70 |
| 2022 6 | 43 | 26 | 69 |
| 2022 5 | 105 | 50 | 155 |
| 2022 4 | 78 | 40 | 118 |
| 2022 3 | 90 | 54 | 144 |
| 2022 2 | 80 | 30 | 110 |
| 2021 1 | 90 | 40 | 130 |
| 2021 12 | 66 | 40 | 106 |
| 2021 11 | 70 | 46 | 116 |
| 2021 10 | 71 | 67 | 138 |
| 2021 9 | 64 | 46 | 110 |
| 2021 8 | 63 | 43 | 106 |
| 2021 7 | 51 | 25 | 76 |
| 2021 6 | 84 | 42 | 126 |
| 2021 5 | 63 | 43 | 106 |
| 2021 4 | 128 | 83 | 211 |
| 2021 3 | 83 | 39 | 122 |
| 2021 2 | 86 | 31 | 117 |
| 2020 1 | 65 | 23 | 88 |
| 2020 12 | 64 | 25 | 89 |
| 2020 11 | 58 | 31 | 89 |
| 2020 10 | 67 | 34 | 101 |
| 2020 9 | 71 | 42 | 113 |
| 2020 8 | 43 | 26 | 69 |
Mostrar todo
